ANTI-SARS-COV-2 DURG
The present invention relates to an anti-SARS-CoV-2 drug including, as an active ingredient, a compound represented by formula (I):[wherein R<sup>1</sup> is C<sub>1</sub>-C<sub>8</sub> alkyl or the like; and R<sup>2</sup>-R<sup>9</sup> is hydrogen, halogen, hydroxyl, or Q-(Ci-Cs alkyl), (Q is O, NH, or S) or the like.], or a pharmaceutically acceptable salt thereof..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 29. März Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
BABA MASANORI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-03-29, Last update posted on www.tib.eu: 2023-08-15, Last updated: 2023-08-18 |
|---|
| Patentnummer: |
EP4154884 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017142334 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017142334 | ||
| 003 | DE-627 | ||
| 005 | 20230818085106.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230614s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017142334 | ||
| 035 | |a (EPA)EP4154884 | ||
| 035 | |a (EPA)78708496 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a BABA MASANORI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ANTI-SARS-COV-2 DURG |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-03-29, Last update posted on www.tib.eu: 2023-08-15, Last updated: 2023-08-18 | ||
| 520 | |a The present invention relates to an anti-SARS-CoV-2 drug including, as an active ingredient, a compound represented by formula (I):[wherein R<sup>1</sup> is C<sub>1</sub>-C<sub>8</sub> alkyl or the like; and R<sup>2</sup>-R<sup>9</sup> is hydrogen, halogen, hydroxyl, or Q-(Ci-Cs alkyl), (Q is O, NH, or S) or the like.], or a pharmaceutically acceptable salt thereof. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a OKAMOTO MIKA |4 aut | |
| 700 | 0 | |a TOYAMA MASAAKI |4 aut | |
| 700 | 0 | |a HASHIMOTO YUICHI |4 aut | |
| 700 | 0 | |a HASHIMOTO HIROMASA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 29. März |
| 773 | 1 | 8 | |g year:2023 |g day:29 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/78708496/publication/EP4154884A1?q=EP4154884 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 29 |c 03 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 29 |c 03 | ||